S
Power Law company profile
Shenzhen Salubris Pharmaceuticals
Biotech & Life Sciences · Shenzhen, China · Founded 1998 · IPO 2009 Unicorn
Valuation
$7.80B
Market cap · Apr/2026
Revenue
$552M
Latest reported FY
Patent intelligence
$37M patent portfolio · 208 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$37M
0.47% of market cap · 6.3× smaller than top peer Galapagos ($230M)
208 active patent families
Where Shenzhen Salubris Pharmaceuticals innovates
Pharmaceutical drugDiseaseMolecular biologyPharmaceutical SubstancesMedicinal chemistry
Below peer median on Legal, Strategic, Market
Quality vs same-sector peers
Shenzhen Salubris Pharmaceuticals on the five Patsnap quality dimensions
Shenzhen Salubris Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Shenzhen Salubris Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Shenzhen Salubris Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Shenzhen Salubris Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.